NASDAQ:ARNA

Arena Pharmaceuticals, Inc Earning Date

USA |NASDAQ |USD

ARNA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-2.53 $-2.40 $-1.69
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $680.00K $-1.70M $20.00K

Arena Pharmaceuticals, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

ARNA Earnings Date & History Chart

ARNA Earnings & Revenue Forecast

ARNA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 15 $-2.43 $-2.66 $-2.24
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 16 $-9.09 $-10.70 $-5.21
Dec 2022 16 $-8.72 $-11.13 $-5.61

ARNA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.43 $-2.41 $-2.23
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-9.09 $-9.02 $-8.26
Dec 2022 0 / 0 $-8.72 $-8.59 $-8.19

ARNA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 12 $680.00K $0.00 $5.00M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 14 $19.77M $0.00 $260.00M
Dec 2022 16 $25.65M $0.00 $286.40M

ARNA Earnings Date & Revenue History

ARNA Earnings History

|
Show More
Show More

ARNA Revenue History

|
Show More
Show More

Arena Pharmaceuticals, Inc Next Earnings Date & Report

ARNA Next Earnings Date & Report Preview: Sep 2021 (FQ)

ARNA's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 15 analysts, the average EPS estimation for Arena Pharmaceuticals, Inc's next quarterly earnings is $-2.53, with a low EPS estimation of $-3.68, and a high estimation of $-2.24.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-2.53, the last 2 month trend is $-2.51, and the 3 month trend is $-2.17.

Based on 12 analysts, the average revenue estimation is $680.00K, with a low revenue estimation of $0.00, and a high estimation of $5.00M.

Arena Pharmaceuticals, Inc Previous Earnings Dates & Reports

ARNA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Arena Pharmaceuticals, Inc's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ARNA's earnings per share (EPS) was $-2.40, missing the consensus analysts forecast of $-2.17 by -10.52%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 21.21%, and lower than the same period a year before (Jun 2020) by 49.07%.

Revenues were $-1.70M.

The company reported a net income of $-146.09M.

Free cash flow for the quarter was $-94.04M , compared to $-120.09M last quarter and $-77.78M a year before.

ARNA ended the quarter with $43.50M in total debt, a decrease of -2.44% compared to the previous quarter, and a decrease of -8.61% compared to the same quarter a year before.

ARNA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Arena Pharmaceuticals, Inc's previous annual earnings date was Feb 23, 2021 for its fiscal year ended Dec 31, 2020.

ARNA's earnings per share (EPS) was $-7.40, missing the consensus analysts forecast of $-7.13 by 3.79% , and lower than the previous year's EPS (Dec 2019) by -196.86%.

Revenues were $319.00K, worse than the forecast of $720.00K by -55.69%, and down by -99.96% from previous year's revenue.

The company reported a net income of $-404.73M.

Arena Pharmaceuticals, Inc reported a free cash flow of $-353.91M for its fiscal year, compared to $563.88M a year ago.

The company ended the fiscal year with $45.61M in total debt, a decrease of -7.72% compared to the previous year.